Presse/médias
- 100 - 125 sur 134 résultats
Résultats de recherche
-
Who will receive it, is it dangerous, what about the elderly? The answers to your questions about the 3rd dose of anti-Covid vaccine
8/08/21
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Agenda - CHMP agenda of the 16-19 August 2021 meeting: written procedure
16/08/21
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Les éclaireurs - L'âgisme et le mouton
21/08/21
1 Contribution média
Presse/Médias: Activités publiques
-
Coronavirus transmission: Belgian study says vaccination decreases infection risk
29/08/21
2 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
Does the vaccine reduce the risk of coronavirus transmission? Here are the results of a study by Sciensano
29/08/21 → 30/08/21
2 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
Coronavirus: why is the situation now more worrying in Liège?
22/09/21
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Première étude de biomonitoring wallon
8/10/21
1 Contribution média
Presse/Médias: Commentaire d'expert
-
Agenda - PRAC draft agenda of meeting 25-28 October 2021
25/10/21
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
-
“The policies are not in the pay of the pharmaceutical industries”, assures Jean-Michel Dogné
3/12/21
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
At 62 years old, Anne “suffers from collagenosis” and thinks that she cannot receive the anti-covid vaccine: “I have too much immunity”
3/01/22
2 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
The 10 reasons to hope that 2022 marks the end of the Covid-19 epidemic
5/01/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Agenda - CHMP agenda of the 24-27 January 2022 meeting
24/01/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Agenda - PRAC draft agenda of meeting 4-7 April 2022
4/04/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Man bites back at killer dog bites with smart optics
11/04/22 → 12/04/22
3 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
Coronavirus vaccine: is the 4th dose useful and for whom?
16/04/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Agenda - PRAC draft agenda of meeting 2-5 May 2022
2/05/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet
23/06/22
5 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
New Nets Data Presented At International Society On Thrombosis And Haemostasis (ISTH) Congress'
13/07/22
101 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
Volitionrx (VNRX) Presents New NETs Data
13/07/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Unequal Access to Monkeypox Shots Gives Europe Pandemic Flashbacks
17/08/22
2 éléments de Couverture média
Presse/Médias: Commentaire d'expert
-
Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation
21/09/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
The campaign is launched, the figures are going up: should we be revaccinated against Covid-19?
7/10/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Data on Lupus Discussed by Researchers at Catholic University of Louvain (UCLouvain) (Variability Among Commercial Batches of Normal Pooled Plasma In Lupus Anticoagulant Testing)
7/11/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert
-
Findings from University of Monastir Update Knowledge of COVID-19 (Teaching Transition In Biochemistry Laboratories During the Covid-19 Outbreak: Tunisian Experience)
22/11/22
1 élément de Couverture média
Presse/Médias: Commentaire d'expert